Skip to content
Screener

Reported August 14, 2026 · Before market open

EPS-$0.03

Next report

Date not yet announced

Versus estimates

FAQ

When did Liminatus Pharma, Inc. report Q2 2026 earnings?
Liminatus Pharma, Inc. (LIMN) reported Q2 2026 earnings on August 14, 2026 before market open.
What were Liminatus Pharma, Inc.'s Q2 2026 revenue and EPS?
Liminatus Pharma, Inc. reported eps of $-0.03 for Q2 2026.
How did Liminatus Pharma, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 40.0% from $-0.05.
Where can I find Liminatus Pharma, Inc.'s Q2 2026 SEC filings?
You can read the 10-Q periodic report (0001104659-26-097304) directly on SEC EDGAR. The filing index links above go to sec.gov.